CSCIFOTCPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends December 31

COSCIENS Biopharma Inc.

Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 20-F on Mar 25, 2026

$6.49+0.00 (0.00%)

Close on Oct 19, 2026

Community

Notes and questions about COSCIENS Biopharma from other investors

Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Parsed from the XBRL in COSCIENS Biopharma's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-4 reverse split on May 3, 2024
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is CSCIF.

Revenue growth-11.6% · median 3.2%

Gross margin38.0% · median 46.9%

Operating margin-98.8% · median -1.1%

Advertisement
300 × 250